A naturalistic study of orally administered vs. inhaled legal market cannabis cannabinoids exposure, intoxication, and impairment.
Published studies examining the effects of cannabis have largely utilized forms of cannabis that are not representative of the legal market products currently available. The present study aimed to characterize naturalistic use of legal market flower and edible products by examining associations among blood cannabinoids and amount of THC consumed as well as physiological, cognitive, and subjective effects in users of edible and flower forms. Eighty-four participants who used cannabis at least 1 × week (55 flower cannabis using participants 29 edible cannabis using participants mean age 31.95 years, 44% female) participated. At the experimental appointment in our mobile laboratory, participants completed a blood draw to assess plasma cannabinoids, measures of heart rate, subjective drug effects, and cognition both before and after ad libitum use of legal market flower or edible cannabis. Average self-reported THC consumed was 15.97 mg (SD 22.40) in edible users and 51.25 mg (SD 45.23) in flower users. In the edible group, but not the flower group, strong correlations emerged between self-reported ad libitum THC consumed and plasma THC. Plasma THC was significantly higher after use of inhaled cannabis, but similar levels of plasma THC metabolites and similar levels of subjective intoxication and verbal memory impairment were observed in both flower and edible users. Findings support strong correlations among ad libitum THC consumed and THC plasma levels after edible cannabis use and suggest few differences in intoxication and impairment between edible and flower cannabis users after ad libitum use. This novel study provides important preliminary data on the pharmacology and effects of legal market edible cannabis.